This analysis describes what Writer's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
The updated terms establish clearer scope (these terms apply to free, trial, and paid versions; Enterprise is separate) and expand the list of prohibited uses. Users may no longer reverse engineer, scrape, or attempt to derive components of the Services; use the platform for competitive analysis or to develop competing products; or misrepresent AI-generated output as human-created. The terms also explicitly prohibit processing of HIPAA-regulated health information. Users can review the full updated terms to understand which specific uses are now restricted.
View change record →How other platforms handle this
The license granted to you for the App is a limited, non-transferable license to use the App on Mac product that you own or control and as permitted by the Usage Rules that are part of the terms of service in the Mac App Store.
Teladoc Health grants you a limited, non-exclusive, non-sublicensable, revocable, non-transferable license to use the Platforms in accordance with these Terms and Conditions.
Subject to the terms and conditions of these Terms, Faire grants you: (a) a non-transferable, non-exclusive, revocable, limited license, with no right to sublicense, to use and access the Services, and to view any Collective Content to which you are permitted access...
"Subject to these Terms, we grant you and anyone authorized by you to access and use the Services under your account a limited, non-exclusive, non-transferable (except as otherwise permitted under these Terms) right to access and use the Services during the your subscription term for your internal business purposes.Excerpt from Writer's Terms of Service
Get the weekly coverage letter
Companies change their terms without announcing it. We capture governance documents, compare each new version with the last, and publish what changed, with the source text behind it. One email a week on what we found and what we could not reach.
The clause states: “Subject to these Terms, we grant you and anyone authorized by you to access and use the Services under your account a limited, non-exclusive, non-transferable (except as otherwise permitted under these Terms) right to access and use the Services during the your subscription term for your internal business purposes.”
ConductAtlas has identified this type of provision across 250 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Writer.